NeuraLace Medical has developed a proprietary neuromodulation platform for direct and selective stimulation of sensory nerve fibers to manage neuropathic pain.
The unique capability of our platform is its use of our novel NeuraSense hardware architecture to monitor treatment performance with high-resolution data allowing for real-time co-optimization of the treatment hardware and algorithms to maximize the therapy for pain relief. This approach is quite novel when compared to the industry standard of generic preset stimulation programs. As a result, our team is utilizing the platform to develop non-invasive diagnostic profiles that accurately detect specific neuropathic states.
Initial platform applications have been demonstrated in multiple neuropathic pain states.
Understanding Neuropathic Pain
Peripheral sensory nerve fibers (Aβ, Aδ and C fibres) communicate pain by firing off a set of electrical signals. The signals fire in a specific code that is unique to each nerve fiber and is a bit like a software command. Injury or disease that cause damage to these peripheral sensory nerve fibers throw off these signaling codes, leading to excitation and a loss of inhibition of pain signals, eventually causing chronic neuropathic pain.
How AXON Works
At NeuraLace, we are developing hardware to assist the communication between nerve cells by making an instantaneous prediction as to what the healthy code should be, and then firing off in that pattern, overwriting the signals for pain and restoring the balance which results in pain relief. We call this precision neuromodulation. Using deep learning as a computational paradigm, we are constantly advancing Axon Therapy, from optimizing our algorithms to hardware, to develop the most intelligent solution to deliver significant pain relief. Providing sustainable pain relief restores quality of life for patients, but also improves other problems such as anxiety, depression, disturbed sleep and high prescription drug use.